Szoleczky Réka, Kovács Anita, Berkó Szilvia, Budai-Szűcs Mária
Egis Pharmaceuticals Plc., Laboratory of Finished Product Analytical Development 3, Bökényföldi Str. 116-120, 1165 Budapest, Hungary.
Institute of Pharmaceutical Technology and Regulatory Affairs, University of Szeged, Eötvös Str. 6, 6720 Szeged, Hungary.
Pharmaceutics. 2024 Feb 23;16(3):313. doi: 10.3390/pharmaceutics16030313.
This study focuses on how to define an Analytical Target Profile (ATP) which is intended for use in practice and on facilitating the selection of in vitro release test (IVRT) technology for diclofenac sodium topical hydrogel and cream. The implementation involves incorporating the new draft guidelines of the International Council for Harmonisation (ICH Q14) and USP (United States Pharmacopeia) Chapter 1220. Four IVRT apparatuses were compared (USP Apparatus II with immersion cell, USP Apparatus IV with semisolid adapter, static vertical diffusion cell, and a new, in-house-developed flow-through diffusion cell) with the help of the ATP. Performance characteristics such as accuracy, precision, cumulative amount released at the end of the IVRT experiment, and robustness were investigated. We found that the best apparatus for developing IVRT quality control (QC) tests in both cases was USP II with an immersion cell. All four different IVRT apparatuses were compared with each other and with the data found in the literature.
本研究聚焦于如何定义一个拟用于实际的分析目标轮廓(ATP),以及如何为双氯芬酸钠 topical 水凝胶和乳膏选择体外释放试验(IVRT)技术提供便利。实施过程涉及纳入国际协调理事会(ICH Q14)和美国药典(USP)第1220章的新草案指南。借助ATP对四种IVRT装置进行了比较(带浸没池的USP装置II、带半固体适配器的USP装置IV、静态垂直扩散池以及一种新的、内部开发的流通扩散池)。研究了诸如准确性、精密度、IVRT实验结束时的累积释放量以及稳健性等性能特征。我们发现,在这两种情况下,用于开发IVRT质量控制(QC)测试的最佳装置是带浸没池的USP II。将所有四种不同的IVRT装置相互进行了比较,并与文献中的数据进行了比较。